Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$738,083.00
Apr 1, 2013
The role of bacterial silencing proteins in virulence gene expression
$454,685.00
Apr 1, 2013
Temperature measurement in cortical bone and bone marrow during magnetic resonance guided focused ultrasound thermo-therapy in a porcine model
$2,266,046.00
Apr 1, 2013
Toward epigenetic therapy for colon cancer
$509,660.00
Apr 1, 2013
Targeted nanomedicines for gene therapy applications.
$90,000.00
Apr 1, 2013
Screening for Novel NS5B-Inhibitors: Toward Selective and Potent Hepatitis C Virus (HCV) Therapy.
$409,127.00
Apr 1, 2013
Small Molecule Inhibitors of Phagocytosis as Replacement Therapy for IVIG
$2,436,736.00
Apr 1, 2013
Viral and Human Genetic Predictors of Response to HIV Therapies
$4,402,400.00
Apr 1, 2013
Directing Cellular Identity to Move Towards Progenitor Cell Therapies
$127,500.00
Apr 1, 2013
Bone marrow-derived stem cells as a vehicle for delivery of therapeutic genes into the central nervous system of a mouse model of amyotrophic lateral sclerosis
$758,564.00
Apr 1, 2013
Connecting the Cell-Type Specific Chromosome Architecture to Gene Regulation, Development and Diseases